chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About one day after the shot, I experienced a dull headache that has lasted almost one week; Nausea; Feeling unwell; On the 6th day after the shot, I experienced severe vertigo and several bouts of vomiting; On the 6th day after the shot, I experienced severe vertigo and several bouts of vomiting; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Mar2021 at 09:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and allergies (unspecified). Allergies to medications, food, and other products was reported as not to my knowledge. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 06Mar2021 at 16:00, about one day after the shot the patient experienced a dull headache that lasted almost one week, nausea, and feeling unwell. On an unknown date in Mar2021, on the 6th day after the shot, the patient experienced severe vertigo and several bouts of vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dull headache that lasted almost one week was recovered on an unknown date in Mar2021. The clinical outcome of the events nausea, feeling unwell, severe vertigo and several bouts of vomiting was recovering at the time of this report.   No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
Took the vaccine on the 24. Next morning I has pain in my arm and was swollen and itchi, hot and red. Placed an Icepack but the swelling,redness and itchiness is not gone. Went toda to a pharmacy and the pharmacist recommended to take Benedril and to let you know I have my arm swollen, red and itchi.
oxygen meter at home dropped down to 87; heaviness in my chest; dizzy; A spontaneous report was received from a consumer concerning herself a 73-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events oxygen saturation decreased, chest discomfort, dizziness.  The patient's medical history was not provided. Concomitant medications reported were enalapril, atenolol, atorvastatin, aspirin and metformin.  On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) oxygen meter at home dropped down to 87, heaviness in her chest and dizzy. She called her doctor and he said she should be okay it is normal for it fluctuate.  Treatment details was not included   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), oxygen saturation, chest discomfort and dizziness were unknown.
Provider administered covid-19 Bivalent Booster 0.2mL (NDC 80777-0283-99) instead on Moderna Bivalent dose 0.25mL (NDC 80777-282-99) as second dose of primary series. No adverse reaction.
Had his shots on September 6, 2005, both in the left arm. The next day he had swelling, rash, and bruise on at shot location, which got progressively worse and became significant over the next few days. He also developed a stuffy nose that made it difficult for him to sleep on Thursday night. The symptoms increased on Sunday night when his breathing became difficult, he was "hitching" and grunting with each breath. We took him to the emergency rooom on 9/11/05 and his oxygen was at 91%. He was given a nebulizer with oxygen at 10 and when we brought him home we gave him another treatment at midnight. He was doing much better the next day. On 9/14 (today) he still has bruising, redness and soreness at the shot site.
pt recv vax 28MAY96 & arthritis, neck pain;30MAY h/a, myalgias;31MAY lymphadenopathy;dx viral synd;
Report of left shoulder pain with swelling started the next day post vaccination. Treatment: Advil and ice. Outcome: No improvement with pain, ice helped with swelling. Continues to work, no interference with ADLs.  Consulted his primary doctor via telemedicine.
no adverse effect reported; the 43-year-old patient recieved a dose of Gardasil 9 four months ago.; This spontaneous report has been received from a pharmacist regarding to a 43-year-old female patient. The patient's concurrent condition, medical history, concomitant medication, drug allergies or reaction were not reported.   On an unspecified day in December 2018 (reported as "4 months ago"), the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), intramuscular (lote #, expiration day, dose and anatomical location of vaccine were not reported) for prophylaxis (Inappropriate age at vaccine administration). No adverse effects were reported.
At 14:10, client has 4cm X 4cm swollen area with scant redness. Ice pack applied. No abnormal signs or symptoms of anaphylaxis.
This spontaneous report as received from a registered nurse refers to an adult patient of unknown age. On an unknown date the patient was inadvertently vaccinated with only one pediatric dose of RECOMBIVAX HB injection (lot # not reported), intramuscular, instead of two pediatric doses, resulting in a less than full dose. No adverse effects. Additional information has been requested.
This solicited report as received from a pharmacist, as part of a marketing research program, refers to an elderly (in his early 90's) male patient. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On an unknown date in 2011, the patient was vaccinated with 1 dose of ZOSTAVAX, one time injection (route of administration, lot# and expiry date were not reported). On an unknown date in 2016, the patient experienced mild case of shingles. The patient recovered/resolved with sequelae from the event on an unknown date, in 2016. Causality assessment was not provided. This is one of two reports received from the same reporter. Additional information is not expected, as there was no consent for further contact.
Resident undergoing wound care. Vaccine given and approximately 5 minutes after administration, this resident noted to have rapid jerking eye movement determined to be seizure activity. After the seizure, resident stabilized. Resident was asked if she was feeling ok and she nodded her head yes in agreement. Resident has a history of seizures and is being treated with Dilantin and Keppra.
mom states immediate rash and itching within 30 min of vaccine following chest pain and numbness in hands. mom then took child immediately to local ER.  mom states child was given Benadryl and a steroid shot while in ER, was written a prescription for Medrol dose pack to take and was advised to not receive another dose of meningits vaccine due to allergic reaction
Patient received COVID vaccine 4/7/21, tested positive for COVID on 8/5/21 & 8/14/21 (tested negative COVID 8/13/21)  8/5/21:  HPI A 65 y.o. male diabetes and hypertension with penicillin allergy presenting as a trauma alert.  Patient was on a moped swerved to avoid a car and then fell off the moped onto his right side.  Does not have any loss of consciousness was not wearing helmet.  Complaining of significant pain in his right ankle with obvious deformity exposed also complaining of right upper extremity pain denies any pain anywhere else. Tourniquet placed above right ankle at 655pm.   8/16/21: Hospitalization Admit Date/Time: 8/5/2021  7:11 PM Discharge Date: 08/16/21 Referring provider name and address:  No referring provider defined for this encounter.   Chief Concern, Brief History of Present Illness, and Hospital Course 65 yr old male admitted due to moped accident on 8/5. Upon hospitalization the following concerns were noted: Open trimalleolar fracture, scaphoid fracture, pulmonary nodules and COVID 19 positive.  Right trimalleolar fracture was fixed on 8/6 by ortho in OR. Scaphoid fracture was considered non-op.  Pulmonary nodules were incidental findings and it is recommended to have follow up with PCP. He was asymptomatic with COVID the whole hospital stay and completed the 10-14 day of isolation required per health department. PT recommended HWA. Patient is tolerating room air and diet.  Alert and oriented.  Having normal BM's and voiding on own.  Pain well controlled with oral pain medications.  Patient is medically ready to be discharged home with his daughter who is aware that he was COVID positive.    Follow up with PCP in 1 week for post-hospitalization visit and for pulmonary nodules Follow up with Ortho on 8/27     Surgeries and Procedures Procedures performed in this encounter Procedures ? Case Request Operating Room: EXTERNAL FIXATION, LOWER EXTREMITY #1 in OR1A (trauma room): I&D, Ex-fix R open Trimal Supine, berchtold w/ extension, C-arm, , ortho soft tissue, Cysto tubing, Synthes large ex-fix w/ extra long bars, splint cart  Pulmonary nodules    Overview Addendum 8/12/2021  8:27      Incidental finding on CT Findings may be infectious or inflammatory Informed 8/7 Recommend short-term follow-up CT in 3 months to confirm resolution and/or stability       COVID-19   Overview Addendum 8/15/2021  7:09 AM       Isolation protocol Tolerating room air  Mobility and IS Discontinued tele but continued pulse oximetry Monitor respiratory status Must stay in isolation for 20 days since 1st positive test (8/25) per policy.  Per Health department, he could discharge and if remains /asymptomatic, would only isolate for 14 days - Covid test: negative 8/13. Positive COVID on 8/14- Will discuss with IPAC today what needs to be done
10cmx16cm area of edema, erythema and warmth. Right upper extremity, slightly tender to palpaiton. Cellulits. Will treat with Abx(s): Augmentin and warm compresses.
Patient developed Bell's Palsy of the left side of face 5 days after the second dose of the vaccine.  Treatment with Prednisone was started on 9/15/22 with no signs of improvement in facial weakness. Treatment with Valtrex prescribed today, 9/20/22.
Vomiting on Thursday night 3/11, loss of taste of smell and taste, fever ranging from 100 to 103, extreme fatigue, muscle aches, headache, chest tightness, O2 sats ranged from 91 to 93. Sunday 3/14  temperature 99, O2 sats 92, chest tightness less than 3/12, headache and body ache improving. (My girlfriend has an oximeter)
This case was reported by a healthcare professional and described the occurrence of decreased therapeutic response in a 35-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). On 31 March 2009, the subject received 1st dose of ENGERIX B (1 ml, unknown, right deltoid). On 7 May 2009, the subject received 2nd dose of ENGERIX  B (1 ml, unknown, left deltoid). On 27 August 2009 the subject received 3rd dose of ENGERIX B (1 ml, unknown, right deltoid), (drug dose administration interval too short). On an unspecified date, the subject's titer was less than 0.1 with a decreased therapeutic response. The nurse reported that the first and second dose were from the same lot number. The third dose was from another lot number. Vaccines were given in the deltoid rotating from right with the first vaccine, left with second vaccine, and right with third vaccine. The nurse reported that the titers were showing that the series of ENGERIX-B that she provided to the workers at her assisted living facility did not work. Specifically the report stated that the subject was not immune and needed to restart series. The subject's titer was less than 0.1. It was determined that the third dose in the series was administered five months from the first vaccine instead of the recommended six months. This is one of nine cases reported by the nurse; see cases A0832033A, A0832034A and A0832035A for female subjects who experienced decreased therapeutic response and drug dose interval too short; and see cases A0832032A, A0832102A, A0832103A, A0832104A, and A0832105A for female subjects who experienced drug dose interval too short.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever) and myalgia (body aches) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On May 7, 2021, patient experienced pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache. At the time of the report, pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
In error, patient was given vaccine outside of recommended dosing schedule. No adverse events per patient and product manufacturer. TWINRIX 2nd and 3rd dose given 1 month apart instead of 5 months. Manufacturer recommended redosing 3rd vaccine in 6 months.
Patient tested positive for Covid-19 around 11 days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid-19 around 11 days after receiving 1st dose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 19-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid-19 around 11 days after receiving 1st dose). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid-19 around 11 days after receiving 1st dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information was not provided by the reporter.    Reporter did not allow further contact
This is a spontaneous report from a contactable Physician. A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at the first single dose for covid-19 immunisation .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  Immediately after receiving the first dose of the vaccine, the patient reported having dizziness and tingling throughout her body, she could not feel her hands, the patient was not anxious. After that, her heart began to pound and it was difficult for her to breathe, after a minute she felt her heartbeat begin to normalize. After 30 minutes she began to normalize, but she went to the emergency room and began to feel nausea, her body hurt and her heart rate was 140 bpm, the episode lasted 30 seconds. The outcome of events was unknown.  Information on the Batch/Lot number has been requested.
Systemic: Dizziness / Lightheadness-Severe, Additional Details: Patient fell from a standing position to the floor. He was conscious and was responsive. He described feeling a dizziness and said he felt that it had passed. The paramedics were called, offered to take him to the hospital, and he did not. The patient was escorted to his companion's vehicle by the paramedics and companions.
Immediately dizzy, nauseous and fatigue lasted 2 days.   One week later (5/12)  had severe allergic reaction including violent diarrhea  with severe cramping and pain, and swollen lips, tongue, face, hands and feet.  Acute swelling and diarrhea lasted 12 hours.   Ongoing angioedema lasted 4 days and moved from mouth to face and hands and feet.    No previous food allergies or allergic reactions.
redness is getting wider; it's all red around; it's itchy; had a little lump on the injection site; had a little headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness is getting wider), VACCINATION SITE MASS (had a little lump on the injection site), HEADACHE (had a little headache), VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation and Osteoporosis.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE MASS (had a little lump on the injection site) and HEADACHE (had a little headache). On 20-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy). On an unknown date, the patient experienced ERYTHEMA (redness is getting wider). On 13-Feb-2021, VACCINATION SITE MASS (had a little lump on the injection site) and HEADACHE (had a little headache) had resolved. At the time of the report, ERYTHEMA (redness is getting wider), VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided. Treatment medication was not reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender who on 03-NOV-2011, the patient was vaccinated with RECOMBIVAX HB dose 1, 1 ml (route and lot # not provided). On 26-JAN-2012, the patient was vaccinated with RECOMBIVAX HB dose 2, 1 ml (route and lot # not provided). On 12-FEB-2013, the patient was vaccinated with RECOMBIVAX HB dose 3, 1 ml (route and lot # not provided). No concomitant medications were reported. The nurse stated there was no adverse effects. This is one of several reports from the same source. Additional information is not expected.
Client contacted on 7/14/2021 reporting after first COVID shot on 4/14/2021 about 24 hours later felt very dizzy and couldn't sleep enough. Headahche, chills unbalanced when walk. Falling asleep while driving. Have Psoriasis, very sensative to medicines historically. Uses inhaler. Can't breath well uses inhaler 2x per day. Has seen PCP. Symptoms were no strength to stand long lengths of time Can hardly go to grocery store. Sits in chair at work is Administrative position. Can't concentrate well . Tested for COVID 4x all negative per report to this RN. Reported started to feel better about 5 weeks after initial COVID vaccine and decided to get 2nd dose after consulting with PCP. (No mention of this in clinic notes for dose #2 on 5/26/2021). Only reported hx. of Psoriasis. Reports a day or two later after 2nd dose started getting symptoms again. Denies any lab work or tests completed or ordered by her PCP mentioned above. Reports looking for another Dr. Reports called doctor and was prescribed Ivermection. Denies knowledge of VAERS report completed by PCP. This RN discussed all of the above information w/ Doctor who encouraged client to f/u with PCP.
Patient presented to the pharmacy on 10/24 to show pharmacist pictures of injection site.  A red rashy, swollen patch of skin was visible an inch or so below the injection site. The issue has resolved, but patient was concerned about effectiveness of vaccine and asked that we report his ADR.
Headache a couple hours ago. Took acetaminophen plus caffeine (generic Excedrin)  Migraine and nausea now.
Narrative: COVID infection following COVID vaccine series 02/17 Pfizer, dose #1 03/10, Pfizer, dose #2 08/09 COVID swab, result; detected 08/09 SARS-COV-2 LINEAGE AY.4 08/09 SARS-COV-2 CLADE 21A DELTA 08/10 pt cc: cough, fatigue, headache, sore throat, loss of taste or smell, rhinorrhea, dyspnea exposure: unknown clinically resolved
Pain at injection site and fatigue about 5 hours after injection, nothing I wouldn't consider "normal". Mild headache and nausea started 10 hours after injection. Took 1000mg Tylenol and went to bed.  Nausea, fever symptoms w/ no fever, pale, extreme fatigue started the next morning. Took 1000mg Tylenol, attempted to go to work, went back home and back to bed to rest.
pt recvd flu vax & 2 days later exp itching, pain, 1 1/2 x 2 1/2 in area of erythema & a 1 x 2 in area of induration; prescribed DPH;
Sore arm; Only sore if she touched it and it only was at the injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PAIN (Only sore if she touched it and it only was at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PAIN (Only sore if she touched it and it only was at the injection site). On 14-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VACCINATION SITE PAIN (Only sore if she touched it and it only was at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  No treatment information was provided.   This case was linked to MOD-2021-214539 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Email added on 14-may-2021.. outcome updated.
Reports slight nausea ~20 minutes after vaccine given Vitals BP 139/102. Denies chest pain, SOB, palpitations. Given water, and observed for 20 minutes. Symptoms resolved.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose# 01/12/2021.pfizer Lot#EL3248 2nd dose:02/02/2021.pfizerLot#EN5318 Diagnosed covid positive: 03/03/2021 Exposure:Home Exposure Symptoms:Runny Nose, Headache
Information has been received from a physician concerning an 80 year old male whose 76 year old wife was vaccinated with a 0.65 nk dose of zoster vaccine live (Oka/Merck) on 16, Feb 2007. She reportedly transmitted varicella to her husband. On 26, Feb 2007, he was diagnosed with chickenpox. Unspecified medical attention was sought. The patient's current status was not reported. There was no product quality complaint involved. No further information was provided. Additional information has been requested.